STAT
MARCH 31, 2025
Dana, a 29-year-old nurse in St. Louis, checks her phone to see if the gig nursing app CareRev still has her scheduled at the local hospital. She’s already arranged child care for her son, but cancellations are common. “It’s a gamble. … I’ll wake up at 5 in the morning, and I’ll find out if I’m canceled or not,” she told us.
The Pharmacist
MARCH 13, 2025
NHS England (NHSE) will be scrapped and brought back into the Department of Health and Social Care (DHSC) 'to put an end to the duplication resulting from two organisations doing the same job', the government has said today. Prime Minister Sir Kier Starmer set out major reforms today, which will include the dissolution of NHSE […] The post NHS England to be scrapped with funding 'reinvested into frontline services' appeared first on The Pharmacist.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
MARCH 10, 2025
Familiar foes in the industry have claimed a slew of jobs in recent months.
Express Pharma
MARCH 16, 2025
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. The following trends not only shaped the sector then but also set the stage for the future of pharma manufacturing, both in India and globally.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
PhRMA
MARCH 12, 2025
Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients. Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
MARCH 4, 2025
As veterinarians, flu scientists, and biosecurity experts, we have watched with growing concern the rise in H5N1 avian influenza in cats. Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.
The Pharmacist
MARCH 5, 2025
Pharmacists should be given 10% of their hours as protected learning time, the Guild of Healthcare Pharmacists (GHP) has suggested in a new national campaign. Speaking to The Pharmacist, GHP primary care chair Laura Buckley said there was significant variation in pharmacist access to protected learning time in GP practices and primary care networks (PCNs) […] The post Campaign for practice pharmacists to have 10% protected learning time appeared first on The Pharmacist.
PharmaVoice
MARCH 21, 2025
Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.
Express Pharma
MARCH 2, 2025
The Indian pharmaceutical industry is evolving rapidly, leading to the emergence of new leadership roles that address the sector’s dynamic global challenges and opportunities. As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role trends are emerging. These roles are designed to strengthen the companies’ operational efficiency, expand their market presence, and foster innovation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Channels
MARCH 31, 2025
Threes still company in the world of pharmacy benefit managers. For 2024, nearly 80% of all equivalent prescription claims were processed by three familiar companies: the CVS Caremark business of CVS Health, the Express Scripts business of Cigna, and the Optum Rx business of UnitedHealth Group. The names havent changed, but shifting relationships and contract shakeups have altered the plot, with Express Scripts stepping into a new lead role.
Drug Patent Watch
MARCH 5, 2025
The Secret Language of Medicines: Uncovering the Science Behind Pharmaceutical Drug Names As professionals in the healthcare and pharmaceutical industries, we've all seen them - the long, complex names of medications that seem to defy pronunciation. But have you ever stopped to think about the process behind creating these names? It's a fascinating world of science and art that's crucial to ensuring patient safety and efficacy.
STAT
MARCH 31, 2025
Heart disease has long been the leading killer of adults, but beyond that stark fact, men and women diverge. From differences at the cellular level of the heart to circulatory structure to symptoms of distress and treatment, researchers are finding new manifestations of gender differences in cardiovascular disease.
European Pharmaceutical Review
MARCH 19, 2025
New results from a trial investigating a synthetic form of psilocybin, administered with psychological support, showed that it extended the time participants with treatment-resistant depression (TRD) were free from depressive symptoms. A single 25mg dose of COMP360 psilocybin had benefit over smaller 1mg and 10mg doses in the 52-week COMP004 follow-up study to the Phase IIb (COMP001 and COMP003) trials.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The Pharmacist
MARCH 13, 2025
Money to develop IT systems to support the roll-out of Pharmacy First was 'not well spent', pharmacist and MP Sadik Al-Hassan has suggested. The Labour MP for North Somerset was speaking at a roundtable focusing on community pharmacy technology in parliament yesterday when he was asked by The Pharmacist for his views on the IT […] The post Pharmacy First IT funding 'not well spent', says pharmacist MP appeared first on The Pharmacist.
Express Pharma
MARCH 20, 2025
Eli Lilly and Company (India) announced the launch of Mounjaro in single-dose vial presentation following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
PharmaVoice
MARCH 3, 2025
Consumers want more from biopharma. Next-generation direct-to-patient programs can deliver.
PhRMA
MARCH 17, 2025
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 31, 2025
I will never forget stepping into the cadaver lab for the first time. As the doors swung open, a sharp, sour wave of formaldehyde hit me and made my stomach churn. I pulled my thin polyester scrub shirt over my nose, but it did little to block the smell, let alone shield me from the bone-chilling temperature. Steel tables surrounded me, each holding a body, and I could see grayish-yellow skin peeking out from beneath the white drapes.
Drug Patent Watch
MARCH 20, 2025
Unlock the Full Potential of Your Pharmaceutical Product: The Power of a CDMO As a pharmaceutical professional, you're constantly looking for ways to bring innovative products to market faster and more efficiently. One key strategy that can help you achieve this goal is partnering with a Contract Development and Manufacturing Organization (CDMO). But what exactly is a CDMO, and how can it benefit your business?
The Pharmacist
MARCH 4, 2025
Almost 120,000 packs of Boots Paracetamol have been recalled because of a packaging error where they are incorrectly labelled as Aspirin on the foil blister. The Medicines and Healthcare products Regulatory Agency (MHRA) has today issued a recall alert for a specific batch of Boots Paracetamol 500mg (16s) and has advised the public to stop […] The post Boots Paracetamol batch recalled after being wrongly labelled as Aspirin appeared first on The Pharmacist.
Express Pharma
MARCH 31, 2025
HRV Global Life Sciences, a virtual integrated pharmaceutical company, delivers the first shipment of anti-diabetic medications to Mendoza, Argentina. The consignment of USFDA-qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system. This was made possible through the leadership of Mendozas Governor Alfredo Cornejo and Indias Ambassador to Argentina, Dinesh Bhatia.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
PharmaVoice
MARCH 10, 2025
Experts say cost and other barriers present challenges to returning to U.S. shores.
Pharma Marketing Network
MARCH 27, 2025
The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Nominated by the HBAs Corporate Partners, these leaders are not only exceptional contributors within their companies but also powerful advocates for health equity and women’s advancement globally, significantly contributing to the HBAs vision of Creating Women Leaders for Life.
STAT
MARCH 27, 2025
When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.
Drug Patent Watch
MARCH 19, 2025
Unlocking Strategic Investment Opportunities in the Pharmaceutical Industry As we navigate the ever-evolving landscape of the pharmaceutical industry, one thing remains constant: the expiration of patents on blockbuster medications. These expirations can have a significant impact on the market, creating opportunities for strategic investment and growth.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
MARCH 13, 2025
A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected. It is estimated around 1,000 patients a year will be able to access the treatment called relugolixestradiolnorethisterone (also known as relugolix combination therapy or Ryeqo). The turnaround from NICE came after the company provided new evidence on […] The post NICE approves daily pill for endometriosis where other treatments have failed appeared first on The Pharmacist.
European Pharmaceutical Review
MARCH 26, 2025
The US Food and Drug Administration (FDA) has approved Blujepa ( gepotidacin ) antibiotic for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients aged 12 years old and over. The first-in-class bactericidal drug is indicated for such infections caused by E scherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis.
PharmaVoice
MARCH 31, 2025
The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.
Expert insights. Personalized for you.
341 
Let's personalize your content